CD40LG and COVID-19: An initial study on platelets from mild and severe disease COVID-19 patients, found platelets prone to release certain cytokines including IL-1β and CD40L, while many others including IFN-α, TNF-α and TNF-β, Eotaxin, and others were reduced.